Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Voriconazole in clinical practice
Małgorzata Mikulska, Andrea Novelli, Franco Aversa, et al.
Journal of Chemotherapy (2012) Vol. 24, Iss. 6, pp. 311-327
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Johan Maertens, Issam Raad, Kieren A. Marr, et al.
The Lancet (2015) Vol. 387, Iss. 10020, pp. 760-769
Closed Access | Times Cited: 827
Aspergillosis in Chronic Granulomatous Disease
J. D. King, Stefanie Henriet, Adilia Warris
Journal of Fungi (2016) Vol. 2, Iss. 2, pp. 15-15
Open Access | Times Cited: 65
Simultaneous estimation of voriconazole, moxifloxacin, and pirfenidone in rabbit lacrimal matrix using LC-MS/MS: an application to preclinical ocular pharmacokinetics
Amol Chhatrapati Bisen, Sristi Agrawal, Sachin Nashik Sanap, et al.
Analytical Methods (2023) Vol. 15, Iss. 18, pp. 2234-2243
Closed Access | Times Cited: 20
Clinically relevant drug–drug interactions between antiretrovirals and antifungals
Ramya Krishna Vadlapatla, Mitesh Patel, Durga Paturi, et al.
Expert Opinion on Drug Metabolism & Toxicology (2014) Vol. 10, Iss. 4, pp. 561-580
Open Access | Times Cited: 59
Invasive Fungal Infections in the Intensive Care Unit
Luis Ostrosky‐Zeichner, Mohanad Al‐Obaidi
Infectious Disease Clinics of North America (2017) Vol. 31, Iss. 3, pp. 475-487
Closed Access | Times Cited: 59
The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
Andrzej Czyrski, Matylda Resztak, Paweł Świderski, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1961-1961
Open Access | Times Cited: 38
Development and Characterization of Voriconazole-loaded Nanostructured Lipid Carriers for Enhanced Topical Antifungal Therapy
M. Mohapatra, D. Pradhan, Snehamayee Mohapatra, et al.
BioNanoScience (2025) Vol. 15, Iss. 2
Closed Access
How to manage aspergillosis in non-neutropenic intensive care unit patients
Matteo Bassetti, Elda Righi, Gennaro De Pascale, et al.
Critical Care (2014) Vol. 18, Iss. 4
Open Access | Times Cited: 43
An Enantioselective Synthesis of the Key Intermediate for Triazole Antifungal Agents; Application to the Catalytic Asymmetric Synthesis of Efinaconazole (Jublia)
Keiji Tamura, Naoya Kumagai, Masakatsu Shibasaki
The Journal of Organic Chemistry (2014) Vol. 79, Iss. 7, pp. 3272-3278
Open Access | Times Cited: 43
Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development
Elham Ghobadi, Shahnaz Saednia, Saeed Emami
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114161-114161
Closed Access | Times Cited: 20
Efficacy and safety of isavuconazole versus voriconazole for the treatment of invasive fungal infections: a meta-analysis with trial sequential analysis
Jianzhen Weng, Xiaoman Du, Baomin Fang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
An Italian consensus for invasive candidiasis management (ITALIC)
Luigia Scudeller, Claudio Viscoli, Francesco Menichetti, et al.
Infection (2013) Vol. 42, Iss. 2, pp. 263-279
Open Access | Times Cited: 41
Novel Pyrazine Analogs of Chalcones: Synthesis and Evaluation of Their Antifungal and Antimycobacterial Activity
Marta Kučerová-Chlupáčová, Jiřı́ Kuneš, Vladimı́r Buchta, et al.
Molecules (2015) Vol. 20, Iss. 1, pp. 1104-1117
Open Access | Times Cited: 40
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis
Rachel Harrington, Edward Lee, Hongbo Yang, et al.
Advances in Therapy (2016) Vol. 34, Iss. 1, pp. 207-220
Open Access | Times Cited: 33
A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections
Hideo Kato, Mao Hagihara, Nobuhiro Asai, et al.
Mycoses (2023) Vol. 66, Iss. 9, pp. 815-824
Closed Access | Times Cited: 10
Voriconazole Enhances the Osteogenic Activity of Human Osteoblasts In Vitro through a Fluoride-Independent Mechanism
Kahtonna C. Allen, Carlos J. Sánchez, Krista L. Niece, et al.
Antimicrobial Agents and Chemotherapy (2015) Vol. 59, Iss. 12, pp. 7205-7213
Open Access | Times Cited: 29
A Long-Term Survivor of Disseminated Aspergillus and Mucorales Infection: An Instructive Case
Setareh Davoudi, Paolo Anderlini, Gregory N. Fuller, et al.
Mycopathologia (2014) Vol. 178, Iss. 5-6, pp. 465-470
Closed Access | Times Cited: 29
Isavuconazonium sulfate: a triazole prodrug for invasive fungal infections
Derek E. Murrell, John B. Bossaer, Ronald Carico, et al.
International Journal of Pharmacy Practice (2016) Vol. 25, Iss. 1, pp. 18-30
Closed Access | Times Cited: 24
New pharmacological opportunities for the treatment of invasive mould diseases
Marie‐Pierre Ledoux, Elise Toussaint, Julie Denis, et al.
Journal of Antimicrobial Chemotherapy (2017) Vol. 72, Iss. suppl_1, pp. i48-i58
Open Access | Times Cited: 24
An update on the safety and interactions of antifungal drugs in stem cell transplant recipients
Corrado Girmenia, Anna Paola Iori
Expert Opinion on Drug Safety (2016) Vol. 16, Iss. 3, pp. 329-339
Closed Access | Times Cited: 22
Development and validation of a liquid chromatography–tandem mass spectrometry (LC–MS/MS) assay to quantify serum voriconazole
Justin Mak, Kirk K. Sujishi, Deborah French
Journal of Chromatography B (2015) Vol. 986-987, pp. 94-99
Closed Access | Times Cited: 21
Pharmacokinetics of voriconazole after intravenous and oral administration to healthy cats
Polina Vishkautsan, Mark G. Papich, George R. Thompson, et al.
American Journal of Veterinary Research (2016) Vol. 77, Iss. 9, pp. 931-939
Closed Access | Times Cited: 21
Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role?
Alessandro Russo, Simone Giuliano, Antonio Vena, et al.
Diagnostic Microbiology and Infectious Disease (2014) Vol. 80, Iss. 1, pp. 83-86
Closed Access | Times Cited: 21
An Enantioselective Synthesis of Voriconazole
Keiji Tamura, Makoto Furutachi, Naoya Kumagai, et al.
The Journal of Organic Chemistry (2013) Vol. 78, Iss. 22, pp. 11396-11403
Closed Access | Times Cited: 21
Current and future therapies for invasive aspergillosis
Matteo Bassetti, Davide Pecori, Paola Della Siega, et al.
Pulmonary Pharmacology & Therapeutics (2014) Vol. 32, pp. 155-165
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top